“If we are not careful, there are going to be less and less [new] products,” says PhRMA CEO Billy Tauzin, a former Louisiana congressman who chaired the House committee that oversaw the drug industry before retiring from politics in 2004. “Many patient groups are impatiently waiting” for treatments, he says. “There are 2,000 drugs in the pipeline, and the rate of [regulatory] approval is dropping.
Insider says: Er, Billy - I think your shroud is showing.
Big Pharma's Big Problem is mainly of their own making and about their lack of true innovative research and their inappropriate and excessive marketing of duds!
To quote the new FDA slogan: Safety First!
No comments:
Post a Comment